Save Search
Save your searches to access them later
Saved Searches
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Search Paper
Cancel
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Reset All
Filter Icon Filter 1
Export
Sort by: Relevance
  • Research Article
  • 10.1016/j.clml.2024.11.016
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
  • Jun 1, 2025
  • Clinical Lymphoma, Myeloma and Leukemia
  • Andrew H Lipsky + 1 more

  • Research Article
  • Cite Count Icon 2
  • 10.1016/j.clml.2024.11.012
Comprehensive review of bispecific antibody constructs in multiple myeloma: affinities, dosing strategies and future perspectives: Clinical Lymphoma, Myeloma & Leukemia (CLML)
  • May 1, 2025
  • Clinical Lymphoma, Myeloma and Leukemia
  • Johannes M Waldschmidt + 3 more

  • Research Article
  • 10.1016/j.clml.2024.11.010
Outcome of patients with central nervous system multiple myeloma (CNS-MM) treated with CNS-directed radiation therapy: Outcomes of RT for CNS-multiple myeloma
  • Apr 1, 2025
  • Clinical Lymphoma, Myeloma and Leukemia
  • Gohar S Manzar + 20 more

  • Research Article
  • Cite Count Icon 2
  • 10.1016/j.clml.2024.08.003
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
  • Feb 1, 2025
  • Clinical Lymphoma, Myeloma and Leukemia
  • Jing Christine Ye + 12 more

  • Research Article
  • Cite Count Icon 2
  • 10.1016/j.clml.2024.11.015
A phase I study of romidepsin in combination with gemcitabine, oxaliplatin, and dexamethasone in patients with relapsed or refractory aggressive lymphomas enriched for T-cell lymphomas.
  • Dec 1, 2024
  • Clinical Lymphoma, Myeloma and Leukemia
  • Nicole Foley + 10 more

  • Front Matter
  • 10.1016/s2152-2650(24)02411-x
Editorial Board
  • Dec 1, 2024
  • Clinical Lymphoma, Myeloma and Leukemia

  • Addendum
  • 10.1016/j.clml.2024.10.011
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530]
  • Dec 1, 2024
  • Clinical Lymphoma, Myeloma and Leukemia
  • Kathryn Lurain + 29 more

  • Front Matter
  • 10.1016/s2152-2650(24)02412-1
Table of Contents
  • Dec 1, 2024
  • Clinical Lymphoma, Myeloma and Leukemia

  • Research Article
  • Cite Count Icon 1
  • 10.1016/j.clml.2024.11.004
Comparison of Long-Term Outcomes of Double Unit Cord Blood Versus Haploidentical Donor Transplantation in Adult Patients With Acute Lymphoblastic Leukemia Regarding KIR-Ligand Mismatch
  • Nov 19, 2024
  • Clinical Lymphoma, Myeloma and Leukemia
  • Seonghan Lee + 13 more

  • Research Article
  • 10.1016/j.clml.2024.10.015
SOHO State of the Art Updates and Next Questions | Impact of Biologic Markers on Outcomes With Novel Therapy in Chronic Lymphocytic Leukaemia
  • Nov 16, 2024
  • Clinical Lymphoma, Myeloma and Leukemia
  • Dr Abraham Varghese + 1 more